Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: There are times I wonder if there is any point in posting information here.

There are times I wonder if there is any point in posting information here.

posted on Feb 09, 2009 12:30PM

In Germany, with an infringement case, nullifying the patent, in a separate and distinct court, is part of the accepted procedure. Once the validity of the patent is resolved, it reverts back to the court dealing with infringement.

With the confirmation of the patent's validity, the requestor is now in the position of having to negotiate a license, or continue with the expense of fighting the alleged infringement.

By not releasing anything other than the basic details, I would humbly suggest that every potential German infringer is now looking very closely at the viability of obtaining a licence.

While companies may not be as profitable today as they once were is totally irrelevant because a claim for damages would be based on past revenues. Yes, revenues, NOT profits.

The patent holder may also request, via the court, that ALL infringing products be removed from the market(supply chain disruption).

I, for one, am very happy that no further details were given thereby making licensing the MMP Portfolio in Germany that much easier for Alliacense, and I look forward to seeing licenses from companies operating in Germany being announced in the not too distant future.




Be well

Share
New Message
Please login to post a reply